XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenues:        
Product revenues, net $ 322,029 $ 236,623 $ 878,503 $ 632,006
Product royalty revenues 44,487 29,626 108,477 77,486
Contract revenues 15,000 3,214 105,000 69,643
Other revenues 18 6 80 86
Total revenues 381,534 269,469 1,092,060 779,221
Costs and expenses:        
Cost of product revenues (including definite-lived intangible amortization) 22,036 20,205 57,120 38,577
Research and development 269,612 143,184 879,423 420,276
Selling, general and administrative 91,271 75,776 268,577 207,166
Change in fair value of acquisition-related contingent consideration (16,343) 8,012 (1,914) 10,283
Total costs and expenses 366,576 247,177 1,203,206 676,302
Income (loss) from operations 14,958 22,292 (111,146) 102,919
Interest and other income, net 5,555 1,188 10,884 3,818
Interest expense (204) (9,479) (6,527) (29,275)
Unrealized gain (loss) on long term investments 23,045 24,301 (2,343) 20,497
Expense related to senior note conversions     (54,881)  
Income (loss) before provision (benefit) for income taxes 43,354 38,302 (164,013) 97,959
Provision (benefit) for income taxes 7,300 1,425 (500) 2,610
Net income (loss) $ 36,054 $ 36,877 $ (163,513) $ 95,349
Net income (loss) per share:        
Basic $ 0.17 $ 0.20 $ (0.81) $ 0.51
Diluted $ 0.17 $ 0.19 $ (0.81) $ 0.49
Shares used in computing net income (loss) per share:        
Basic 206,796 188,029 202,399 187,632
Diluted 212,610 194,265 202,399 193,754